Showing results (1011-1020 of 11,020) with videos related to
Sort By:
Pageof 1,102
Journal of the National Cancer Institute|June 2, 1993
Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study GroupE R Greenberg, J A Baron, D H Freeman, et al.Journal of the National Cancer Institute|May 19, 1993
Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodesC L Shapiro, R S Gelman, D F Hayes, et al.Journal of the National Cancer Institute|May 19, 1993
Assessment of the carcinogenic potential of chlorinated water: experimental studies of chlorine, chloramine, and trihalomethanesJ K Dunnick, R L MelnickJournal of the National Cancer Institute|April 21, 1993
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancerS A Rosenberg, M T Lotze, J C Yang, et al.Journal of the National Cancer Institute|April 21, 1993
Blood levels of organochlorine residues and risk of breast cancerM S Wolff, P G Toniolo, E W Lee, et al.Journal of the National Cancer Institute|April 21, 1993
Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study GroupH Döhner, A D Ho, J Thaler, et al.Journal of the National Cancer Institute|May 5, 1993
Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal womenM E Reichman, J T Judd, C Longcope, et al.Journal of the National Cancer Institute|May 5, 1993
Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithineR R Love, P P Carbone, A K Verma, et al.Journal of the National Cancer Institute|June 16, 1993
Impact of stromal sensitivity on radiation response of tumorsW Budach, A Taghian, J Freeman, et al.Journal of the National Cancer Institute|July 5, 1995
Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidenceF R Cleghorn, A Manns, R Falk, et al.Pageof 1,102